Use of Proceeds
The proceeds from the sale of the common stock offered by this prospectus are solely for the account of the selling stockholders. We
will not receive any proceeds from the sale of these shares. However, we will receive approximately $9.4 million if all of the warrants to purchase common stock held by the selling stockholders are fully exercised for cash. We cannot guarantee
that the selling stockholders will exercise the warrants or that they will not elect the cashless exercise option in the warrants. We expect to use the net proceeds from any exercise of the warrants for general corporate purposes.
Private Placement of Note and Warrants
The shares of common stock being offered by the selling stockholders are those issuable to the selling stockholders upon the exercise of
warrants that Odyssey issued pursuant to three note and warrant purchase agreements, or purchase agreements.
July 2018
In July 2018, pursuant to the terms of a purchase agreement, we issued and sold (a) promissory notes to two lenders in the aggregate principal
amount of $1.05 million and (b) warrants to purchase shares of Odysseys common stock.
Under the terms of the warrants, as amended,
the holders have the right until July 12, 2024, to purchase up to 196,135 shares of our common stock at an exercise price of $5.756 per share, which represents the official closing price of Odysseys common stock on the Nasdaq Capital Market
immediately preceding the signing of the purchase agreement, upon delivery of a notice of exercise to Odyssey. The warrants provide for customary adjustments to the exercise price and the number of shares of common stock issuable upon exercise in
the event of a stock split, recapitalization, reclassification, combination or exchange of shares, separation, reorganization, liquidation, or the like.
In connection with the execution and delivery of the purchase agreement, Odyssey entered into a registration rights agreement pursuant to
which Odyssey agreed to register the offer and sale of the shares of common stock issuable upon exercise of the warrants, which we refer to as the exercise shares. Pursuant to the registration rights agreement, Odyssey agreed, under certain
circumstances, to include registration of the exercise shares in a registration statement filed with the SEC covering the resale of other exercise shares.
June and September 2023
In June and September 2023, pursuant to the terms of a purchase agreement dated as of March 6, 2023, we issued and sold (a) a promissory note
in the principal amount of $799,359 and (b) warrants to purchase shares of Odysseys common stock.
Under the terms of the warrants,
the holders have the right until March 6, 2026, to purchase up to 211,471 shares of our common stock at an exercise price of $3.78 per share, which represents 120.0% of the official closing price of Odysseys common stock on the Nasdaq Capital
Market immediately preceding the signing of the purchase agreement, upon delivery of a notice of exercise to Odyssey. Upon exercise of the warrants, Odyssey has the option to either (a) deliver the shares of common stock issuable upon exercise or
(b) pay to the holder an amount equal to the difference between (i) the aggregate exercise price payable under the notice of exercise and (ii) the product of (A) the number of shares of common stock indicated in the notice of exercise multiplied by
(B) the arithmetic average of the daily volume-weighted average price of the common stock on the Nasdaq Capital Market for the five consecutive trading days ending on, and including, the trading day immediately prior to the date of the notice of
exercise. The warrants provide for (a) customary adjustments to the exercise price and the number of shares of common stock issuable upon exercise in the event of a stock split, recapitalization, reclassification, combination or exchange of shares,
separation, reorganization, liquidation, or the like; (b) a limitation on the issuance by Odyssey of shares pursuant to the exercise of the warrants to the extent that such shares would, in the aggregate, represent in excess of 19.99% of the number
of shares of our common stock or the total voting power of our securities, each immediately after giving effect so such issuances; and (c) the option for a holder of warrants to notify us if it elects to limit its right to exercise the warrants to
the extent that, after giving effect to such exercise, the holder would beneficially own in excess of 4.99% or 9.99% (as specified by the holder) of our shares of common stock outstanding immediately after giving effect to such exercise.
In connection with the execution and delivery of the purchase agreement, Odyssey entered into a registration rights agreement pursuant to
which Odyssey agreed to register the offer and sale of the shares of common stock issuable upon exercise of the warrants, which we refer to as the exercise shares. Pursuant to the registration rights agreement, Odyssey agreed to prepare and file
with the SEC a registration statement covering the resale of the exercise shares and to use its reasonable best efforts to have the registration statement declared effective by the SEC as soon as practicable thereafter, subject to stated deadlines.
December 2023
In
December 2023, pursuant to the terms of a purchase agreement, we issued and sold (a) a series of promissory notes in the aggregate principal amount of $6.0 million and (b) two tranches of warrants to purchase shares of Odysseys
common stock.
Under the terms of the first tranche of warrants, the holders have the right for a period of three years after issuance to
purchase an aggregate of 1,411,765 shares of Odysseys common stock at an exercise price of $4.25 per share, which represents 120.0% of the official closing price of Odysseys common stock on the Nasdaq Capital Market immediately preceding
the signing of the purchase agreement, upon delivery of a notice of exercise to Odyssey. Under the terms of the second tranche of warrants, the holders have the right for a period of three years after issuance to purchase an aggregate of up to
211,565 shares of Odysseys common stock at an exercise price of $7.09 per share, which represents 200.0% of the official closing price of Odysseys common stock on the Nasdaq Capital Market immediately preceding the signing of the
purchase agreement, upon delivery of a notice of exercise to Odyssey. Upon exercise of the warrants, Odyssey has the option to either (a) deliver the shares of common stock issuable upon exercise or (b) pay to the holder an amount equal to
the difference between (i) the aggregate exercise price payable under the notice of exercise and (ii) the product of (A) the number of shares of common stock indicated in the notice of exercise multiplied by (B) the arithmetic
average of the daily volume-weighted average price of the common stock on the Nasdaq Capital Market for the five consecutive trading days ending on, and including, the trading day immediately prior to the date of the notice of exercise. The warrants
provide the holders with a cashless exercise option if Odyssey has announced payment of a dividend or distribution on account of its common stock. The warrants also include customary adjustments to the exercise price and the number of shares of
common stock issuable upon exercise in the event of a stock split, recapitalization, reclassification, combination or exchange of shares, separation, reorganization, liquidation, or the like.
In connection with the execution and delivery of the purchase agreement, Odyssey entered into a registration rights agreement pursuant to
which Odyssey agreed to register the offer and sale of the shares of common stock issuable upon exercise of the warrants, which we refer to as the exercise shares. Pursuant to the registration rights agreement, Odyssey agreed to prepare and file
with the SEC a registration statement covering the resale of the exercise shares and to use its reasonable best efforts to have the registration statement declared effective by the SEC as soon as practicable thereafter, subject to stated deadlines.
8